MALLORY HALPIN: Open Payments
NPI 1265969851 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,029 in 183 payments from 22 companies in 2025. Trend: 2023 $1,676 · 2024 $2,114 · 2025 $4,029
Food & beverage: $3,929Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 42 | $906 |
| GlaxoSmithKline, LLC. | 33 | $543 |
| Regeneron Healthcare Solutions, Inc. | 18 | $429 |
| GENZYME CORPORATION | 11 | $304 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $301 |
| Amgen Inc. | 13 | $222 |
| Insmed, Inc. | 7 | $184 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $176 |
| Viatris Specialty LLC | 8 | $163 |
| JAZZ PHARMACEUTICALS INC. | 7 | $149 |
Products named: DUPIXENT, TEZSPIRE, AIRSUPRA, NUCALA, GLASSIA, FASENRA, TRELEGY ELLIPTA, Arikayce.
Industry payments across AL — which companies pay providers there.
